Biologist. Technology Developer for Life Sciences. Based in the San Francisco Bay Area.
Intro
Biologist with over 9 years of Biotechnology experience. Expertise in Artificial Intelligence, Single Cell Profiling, Spatial Multi-Omics Technologies. Accomplished new application, instrumentation, and consumable development.
Deepcell
Deepcell’s The REM-I platform combines microfluidics and high-speed imaging in the REM-I instrument, deep learning and computer vision in the Human Foundation Model (HFM), and data analysis and visualization in the Axon data suite.
Cell Viability Profiling using Deep Learning (App Note)Deep Learning Model to Analyze Cell Morphology (Poster- Keystone 2023)Self-Supervised Model to Analyze Cell Morphology (Poster-AACR 2023)The Deepcell Workflow (Poster-AACR 2023)Immune Cells Profiling using Deep Learning Models (Poster-SITC 2023)Profiling and Sorting of Metastatic Cancer Cells from Body Fluids (Poster AGBT 2022)Profiling and Sorting of Metastatic Cancer Cells from Body Fluids (Peer-Reviewed Publication)Deepcell Collaborator at UCLA School of Medicine Wins Prestigious 2021 Geno Saccomanno, MD New Frontiers in Cytology Award (News Release)
Standard Biotools (formerly Fuidigm)
Standard BioTools develops, manufactures, and markets research products for life science analytical and preparatory systems for use in mass cytometry, high-throughput genomics, and single cell genomics applications. Mass cytometry by time-of-flight, used in CyTOF® Systems, is the world’s most advanced single-cell proteomics technology. It has opened new doors to discovery by empowering researchers to interrogate more than 50 markers simultaneously on millions of individual cells, to unveil new cell types, functions and biomarkers in immunology, cancer, stem cells and more.
At Standard BioTools, I developed the RNA and Protein co-detection assay in single cells and on FFPE sections.
Here are links to the works in contributed in:
Co-Detection of RNA and Proteins on the CyTOF platforms (Product Launch Press Announcement)Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice (Peer Reviewed Publication, Gastroenterology, March 2021)Using Cutting Edge Tech, Georgetown Team Proves Pancreatic Cancer Target (Biospace News, January 2021)Disrupting the Cellular Process That Promotes Pancreatic Cancer’s Deadly Growth (Lombardi Comprehensive Cancer Center News Release)
Simultaneous Detection of Protein and mRNA in Jurkat and KG-1a Cells by Mass Cytometry (Cytometry, December 2017)Equivalence of Imaging Mass Cytometry and Immunofluorescence on FFPE Tissue Sections (White Paper)